CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value ($000): $23,840 (100.0% shares, 0.0% debt)

Holdings (20)

SYNTA PHARMACEUTICALS CORP 32.0%
Value ($000) $7,637 Shares 21,696,894 Est. Cost $6.65 Unrealized
SPY SPDR S&P 500 ETF TR 31.9%
Value ($000) $7,594 Shares 37,251 Est. Cost Unrealized
CELATOR PHARMACEUTICALS INC 16.6%
Value ($000) $3,954 Shares 2,246,469 Est. Cost $3.25 Unrealized
AMERICAN CAP LTD 4.0%
Value ($000) $946 Shares 68,621 Est. Cost $14.60 Unrealized
PRONAI THERAPEUTICS INC 2.9%
Value ($000) $688 Shares 45,719 Est. Cost $20.52 Unrealized
NUVEEN SR INCOME FD 1.8%
Value ($000) $418 Shares 72,363 Est. Cost $6.21 Unrealized
XPHDX PIONEER FLOATING RATE TR 1.3%
Value ($000) $321 Shares 29,603 Est. Cost $11.60 Unrealized
BLACKROCK FLOAT RATE OME STR 1.2%
Value ($000) $287 Shares 22,285 Est. Cost $13.37 Unrealized
NUVEEN FLTNG RTE INCM OPP FD 1.1%
Value ($000) $258 Shares 26,314 Est. Cost $9.96 Unrealized
AGILE THERAPEUTICS INC 0.9%
Value ($000) $225 Shares 23,035 Est. Cost $8.00 Unrealized
CIDARA THERAPEUTICS INC 0.9%
Value ($000) $220 Shares 12,812 Est. Cost $17.17 Unrealized
SCM STELLUS CAP INVT CORP 0.9%
Value ($000) $206 Shares 21,380 Est. Cost $10.76 Unrealized -4.4%
BRK/B BERKSHIRE HATHAWAY INC DEL 0.9%
Value ($000) $204 Shares 1,546 Est. Cost $134.20 Unrealized 0.0%
MEDLEY MGMT INC 0.8%
Value ($000) $187 Shares 32,893 Est. Cost $10.12 Unrealized
CM FIN INC 0.6%
Value ($000) $150 Shares 15,020 Est. Cost $10.23 Unrealized
ASSEMBLY BIOSCIENCES INC 0.6%
Value ($000) $136 Shares 18,101 Est. Cost $7.51 Unrealized
ABUS ARBUTUS BIOPHARMA CORP 0.6%
Value ($000) $132 Shares 29,762 Est. Cost $5.48 Unrealized 0.0%
AMERICAN CAP SR FLOATING LTD 0.5%
Value ($000) $129 Shares 13,157 Est. Cost $9.80 Unrealized
MEDLEY CAP CORP 0.5%
Value ($000) $126 Shares 16,693 Est. Cost $9.17 Unrealized
SYNTA PHARMACEUTICALS CORP 0.1%
Value ($000) $22 Shares 62,000 Est. Cost $6.65 Unrealized